102 related articles for article (PubMed ID: 8400614)
1. Two immunogenic peptide conjugates derived from P. falciparum MSA2 give rise to antibodies that crossreact with a nonhomologous 195-kDa malarial protein.
Lord R; Jones G; Saul A
Pept Res; 1993; 6(4):191-4. PubMed ID: 8400614
[TBL] [Abstract][Full Text] [Related]
2. Synthetic peptide immunogens eliciting antibodies to Plasmodium falciparum sporozoite and merozoite surface antigens in H-2b and H-2k mice.
Rzepczyk CM; Csurhes PA; Lord R; Matile H
J Immunol; 1990 Oct; 145(8):2691-6. PubMed ID: 2212657
[TBL] [Abstract][Full Text] [Related]
3. High-titer antisera production using three adjuvants and peptide conjugates derived from malarial surface antigen MSA-2.
Jones GL; Spencer L; Lord R; Edmundson H; Saul AJ
Pept Res; 1991; 4(3):138-41. PubMed ID: 1823184
[TBL] [Abstract][Full Text] [Related]
4. Effect of context and adjuvant on the immunogenicity of recombinant proteins and peptide conjugates derived from the polymorphic malarial surface antigen MSA2.
Jones GL; Spencer L; Lord R; Saul AJ
Vaccine; 1996 Jan; 14(1):77-84. PubMed ID: 8821653
[TBL] [Abstract][Full Text] [Related]
5. High titer response against a malarial antigen depends on the flanking sequence of the immunizing peptide conjugate.
Jones GL; Gale J; Lord R; Edmundson HM; Saul A; Pye D
Pept Res; 1989; 2(4):282-5. PubMed ID: 2520766
[TBL] [Abstract][Full Text] [Related]
6. Protective immunization with invariant peptides of the Plasmodium falciparum antigen MSA2.
Saul A; Lord R; Jones GL; Spencer L
J Immunol; 1992 Jan; 148(1):208-11. PubMed ID: 1727867
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of the T cell response to two allelic forms of a malarial vaccine candidate protein.
Rzepczyk CM; Csurhes PA; Saul AJ; Jones GL; Dyer S; Chee D; Goss N; Irving DO
J Immunol; 1992 Feb; 148(4):1197-204. PubMed ID: 1371134
[TBL] [Abstract][Full Text] [Related]
8. Comparative immunogenicity of free and carrier-conjugated peptides derived from the constant regions of a polymorphic malarial surface antigen.
Jones GL; Lord R; Spencer L; Saul A
Immunol Lett; 1991 Mar; 27(3):209-14. PubMed ID: 2060972
[TBL] [Abstract][Full Text] [Related]
9. Antibodies elicited by a virosomally formulated Plasmodium falciparum serine repeat antigen-5 derived peptide detect the processed 47 kDa fragment both in sporozoites and merozoites.
Okitsu SL; Boato F; Mueller MS; Li DB; Vogel D; Westerfeld N; Zurbriggen R; Robinson JA; Pluschke G
Peptides; 2007 Oct; 28(10):2051-60. PubMed ID: 17875342
[TBL] [Abstract][Full Text] [Related]
10. Peptides for inducing cross-reactive anti-malarial antibodies.
Cheng Q; Liu EX; Saul A
Pept Res; 1994; 7(1):13-9. PubMed ID: 7517231
[TBL] [Abstract][Full Text] [Related]
11. Induction of antibodies against the Plasmodium falciparum p126 antigen in non-responder H-2b and partial-responder H-2d mice using synthetic peptides.
Gilardeau Truffinet M; Bossus M; Camus D; Delplace P; Mazingue C; Diesis E; Tartar A; Moreau S; Gras-Masse H; Banic DM
Pept Res; 1996; 9(2):61-70. PubMed ID: 8738980
[TBL] [Abstract][Full Text] [Related]
12. Synthetic peptides from P. falciparum sexual stage 25-kDa protein induce antibodies that react with the native protein: the role of IL-2 and conformational structure on immunogenicity of Pfs25.
Quakyi IA; Miller LH; Good MF; Ahlers JD; Isaacs SN; Nunberg JH; Houghten RA; Keister DB; Coligan JE; Moss B
Pept Res; 1995; 8(6):335-44. PubMed ID: 8838417
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of synthetic peptides derived from Plasmodium falciparum proteins.
Zerpa NC; Wide A; Noda J; Bermúdez H; Pabón R; Noya OO
Exp Parasitol; 2006 Aug; 113(4):227-34. PubMed ID: 16513113
[TBL] [Abstract][Full Text] [Related]
14. Peptide mapping of conformational epitopes in a human malarial parasite heat shock protein.
Richman SJ; Vedvick TS; Reese RT
J Immunol; 1989 Jul; 143(1):285-92. PubMed ID: 2471738
[TBL] [Abstract][Full Text] [Related]
15. A protective merozoite protein of Plasmodium falciparum shares an epitope with surface antigens of Paramecium.
Sehgal A; Singh NJ; Chakraborty T; Sharma S
Parasite Immunol; 2004 May; 26(5):219-27. PubMed ID: 15491471
[TBL] [Abstract][Full Text] [Related]
16. Peptides reactive with a transmission-blocking monoclonal antibody against Plasmodium falciparum Pfs25: 2000-fold affinity increase by PEPSCAN-based amino acid substitutions.
van Amerongen A; Beckers PJ; Plasman HH; Schaaper WM; Sauerwein RW; Meuwissen JH; Meloen RH
Pept Res; 1992; 5(5):269-74. PubMed ID: 1280492
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
18. Role of the proline residues on the immunogenic properties of a P. falciparum circumsporozoite peptide linked to a carrier protein.
Lise LD; Jolivet M; Audibert F; Fernandez A; Wickstrom E; Chedid L; Schlesinger DH
Pept Res; 1989; 2(1):114-9. PubMed ID: 2520748
[TBL] [Abstract][Full Text] [Related]
19. Immunological fine structure of the variable and constant regions of a polymorphic malarial surface antigen from Plasmodium falciparum.
Jones GL; Edmundson HM; Lord R; Spencer L; Mollard R; Saul AJ
Mol Biochem Parasitol; 1991 Sep; 48(1):1-9. PubMed ID: 1779984
[TBL] [Abstract][Full Text] [Related]
20. A novel 70-kDa Triton X-114-soluble antigen of Plasmodium falciparum that contains interspecies-conserved epitopes.
Ma HW; Ray P; Dhanda V; Das PK; Paliwal S; Sahoo N; Patra KP; Das LK; Singh B; Kironde FA
Exp Parasitol; 1996 Aug; 83(3):322-34. PubMed ID: 8823249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
